Nuclear medicine now safer than everOctober 11, 2007Hospitals are now able to ensure that the correct dose is administered to the 670,000 patients that undergo nuclear medicine procedures every year due to a new device developed by scientists at the National Physical Laboratory (NPL). The number of nuclear medicine procedures has increased by 36% over the last 10 years. 240 NHS sites around the country now use nuclear medicine, mostly for diagnostic scans on areas such as bone, lung perfusion, myocardium and the kidneys. Nuclear medicine is also used in cancer and thyroid therapy. For most diagnostic procedures, radioactive compounds are injected into the body so that physiological images can be made with gamma cameras. Of course, the exact radioactivity of the dose is crucial, not only to the ultimate safety of the patient but also to the quality of the procedure. A low dose can result in inconclusive images whereas a high dose could cause harm to the patient. A new instrument, called 'Fidelis', allows medical physicists to check their in-house instruments against the UK national standards for radioactivity. Once confident that their own instruments are measuring activity correctly, the right dose should always be given to the patient. The instrument is comprised of an ionisation chamber designed by the National Physical Laboratory (NPL), the UK's national measurement institute and a brand new computer-controlled electrometer module from Southern Scientific Ltd (which manufactures and sells the instrument). An ionisation chamber is a gas filled enclosure between two conducting electrodes. When a radioactive source is placed near to the enclosure, gamma-rays emitted by the source ionise the gas - thus creating a current that can be measured by the electrometer. Previously hospitals have used off-the-shelf Radionuclide Calibrators which needed re-calibrating every time new applications for nuclear medicine or a new design of vial came on stream. With Fidelis, this problem is solved. 'The ionisation chamber is an identical version of the master chamber here,' says Piers de Lavison, the Head of Radionuclide Metrology at NPL. 'It's like having NPL in a box - it is a great example of how our work contributes to quality assurance in healthcare, something that touches all our lives.' National Physical Laboratory |
|||||||||||||||||||||
| Related Nuclear Medicine Current Events and Nuclear Medicine News Articles Molecular imaging holds promise for early intervention in common uterine cancer A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. World's most sensitive astronomical camera developed at the Universite de Montreal A team of Université de Montréal researchers, led by physics PhD student Olivier Daigle, has developed the world's most sensitive astronomical camera. Comprehensive cardiac CT scan may give clearer picture of significant heart disease A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia - restricted blood flow to heart muscle tissue - giving a better indication of clinically significant coronary artery disease. Worldwide isotope shortage continues to pose significant challenges SNM recently conducted a survey of nuclear pharmacies-pharmacies that supply the critical radioisotope Technetium-99m, which is used in more than 16 million nuclear medicine tests each year in the United States-to assess, anecdotally, the impact of the worldwide medical isotope shortage. PET/CT scans may help detect recurring prostate cancer earlier A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed. New treatment in sight for ovarian cancer In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness Researchers from Turku, Finland, have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. PET Can Help Guide Treatment Decisions for a Common Pediatric Cancer A new study published in the August issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) is an important tool for depicting the extent of neuroblastoma in some patients, particularly for those in the early stages of the disease. High calcium level in arteries may signal serious heart attack risk Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published in the online edition of Radiology. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. More Nuclear Medicine Current Events and Nuclear Medicine News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||